Poster 58
- May 8, 2023
- 1 min read
Bimekizumab On-Treatment Remission as Defined by the National Psoriasis Foundation: 1-Year Results versus Ustekinumab and Secukinumab in Patients with Moderate-to-Severe Plaque Psoriasis
April Armstrong, Lourdes Pérez-Chada, Mark Lebwohl, Deepak M.W. Balak, George M. Lewitt, Richard B. Warren, Richard G. Langley, Diamant Thaçi, George Han, Heather Herr, Balint Szilagyi, Sarah Kavanagh, Andrew Blauvelt


